Suppr超能文献

一项关于肝病医护人员对隐源性肝性脑病筛查认知的定性研究

A Qualitative Study on Cryptogenic Hepatic Encephalopathy Screening Cognition Among Hepatology Medical Care Personnel.

作者信息

Li Xiao-Qin, Cao Wen, Yin Tian-Tian, Lu Rui, Li Yang, Sha Ya-Yun

机构信息

Department of Infectious Disease, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, 225300, People's Republic of China.

出版信息

J Multidiscip Healthc. 2025 Mar 15;18:1539-1547. doi: 10.2147/JMDH.S508992. eCollection 2025.

Abstract

OBJECTIVE

In this study, we focused on gaining an in-depth understanding on the attitudes and perceptions of hepatology healthcare professionals toward screening for cryptogenic hepatic encephalopathy (CHE), with the goal of providing references for the scientific and standardized implementation of CHE screening.

STUDY METHODS

Based on the phenomenological research method, semi-structured in-depth interviews with nine medical professionals were conducted in March 2023 at the department of hepatology of a tertiary hospital in Taizhou city. The collected data was then integrated and analyzed using the Colaizzi seven-step method.

RESULTS

Three main themes and seven sub-themes were identified: Inadequate knowledge of relevant information (inadequate knowledge of CHE, inadequate knowledge of neuropsychological test tools for CHE); positive attitudes toward screening for cirrhosis CHE; and screening factors (limited human resources, lack of stringent rules from the management, inability to properly use neuropsychological test tools, lack of cooperation from patients and their families, and lack of auxiliary means of screening).

CONCLUSION

Hepatology medical care personnel had a favorable outlook on CHE screening, however there is room for improvement in both their level of knowledge and clinical work. As a result the administrative departments of hospitals should focus on the factors affecting the clinical work of hepatology medical care personnel and formulate corresponding countermeasures. Emphasis should be placed on the screening and management of CHE for early recognition, early intervention, improvement of quality of life, and effective prevention of hepatic encephalopathy.

摘要

目的

本研究旨在深入了解肝病医疗专业人员对隐匿性肝性脑病(CHE)筛查的态度和看法,为科学、规范地开展CHE筛查提供参考。

研究方法

基于现象学研究方法,于2023年3月在台州市一家三级医院的肝病科对9名医学专业人员进行了半结构化深入访谈。然后使用Colaizzi七步法对收集到的数据进行整合和分析。

结果

确定了三个主要主题和七个子主题:相关信息了解不足(对CHE了解不足、对CHE神经心理测试工具了解不足);对肝硬化CHE筛查持积极态度;以及筛查因素(人力资源有限、管理部门缺乏严格规定、无法正确使用神经心理测试工具、患者及其家属缺乏合作以及缺乏辅助筛查手段)。

结论

肝病医护人员对CHE筛查持积极态度,但他们的知识水平和临床工作仍有改进空间。因此,医院行政部门应关注影响肝病医护人员临床工作的因素,并制定相应对策。应重视CHE的筛查和管理,以便早期识别、早期干预、改善生活质量并有效预防肝性脑病。

相似文献

1
A Qualitative Study on Cryptogenic Hepatic Encephalopathy Screening Cognition Among Hepatology Medical Care Personnel.
J Multidiscip Healthc. 2025 Mar 15;18:1539-1547. doi: 10.2147/JMDH.S508992. eCollection 2025.
2
New Simple and Fast Digital Screening Method for Minimal Hepatic Encephalopathy in Cirrhotic Patients.
United European Gastroenterol J. 2025 Jul;13(6):851-852. doi: 10.1002/ueg2.70028. Epub 2025 May 2.
3
Advances in cirrhosis: Optimizing the management of hepatic encephalopathy.
World J Hepatol. 2015 Dec 18;7(29):2871-9. doi: 10.4254/wjh.v7.i29.2871.
5
Diagnosis of covert hepatic encephalopathy without specialized tests.
Clin Gastroenterol Hepatol. 2014 Aug;12(8):1384-1389.e2. doi: 10.1016/j.cgh.2013.12.020. Epub 2013 Dec 19.
7
Prevalence and risk factors of covert hepatic encephalopathy in cirrhotic patients: A multicenter study in China.
J Dig Dis. 2023 Feb;24(2):122-132. doi: 10.1111/1751-2980.13171. Epub 2023 May 11.
8
A shortened Stroop test to identify covert hepatic encephalopathy and predict overt hepatic encephalopathy in patients with cirrhosis.
J Gastroenterol. 2022 Dec;57(12):981-989. doi: 10.1007/s00535-022-01925-0. Epub 2022 Sep 29.
9
Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis.
JHEP Rep. 2023 Jan 18;5(4):100671. doi: 10.1016/j.jhepr.2023.100671. eCollection 2023 Apr.
10
A simple covert hepatic encephalopathy screening model based on blood biochemical parameters in patients with cirrhosis.
PLoS One. 2022 Nov 30;17(11):e0277829. doi: 10.1371/journal.pone.0277829. eCollection 2022.

本文引用的文献

2
EASL Clinical Practice Guidelines on the management of hepatic encephalopathy.
J Hepatol. 2022 Sep;77(3):807-824. doi: 10.1016/j.jhep.2022.06.001. Epub 2022 Jun 17.
3
Management of hepatic encephalopathy in Germany: a survey among physicians.
Z Gastroenterol. 2020 Jan;58(1):49-56. doi: 10.1055/a-1010-6974. Epub 2020 Jan 13.
4
Quality of life in patients with minimal hepatic encephalopathy.
World J Gastroenterol. 2018 Dec 28;24(48):5446-5453. doi: 10.3748/wjg.v24.i48.5446.
5
Sleep disturbances in patients with liver cirrhosis: prevalence, impact, and management challenges.
Nat Sci Sleep. 2018 Nov 2;10:369-375. doi: 10.2147/NSS.S186665. eCollection 2018.
6
Health professionals' perceptions of developing dementia services in primary care settings in China: a qualitative study.
Aging Ment Health. 2019 Apr;23(4):447-454. doi: 10.1080/13607863.2018.1426717. Epub 2018 Jan 22.
7
Hospital readmissions in decompensated cirrhotics: Factors pointing toward a prevention strategy.
World J Gastroenterol. 2017 Oct 7;23(37):6868-6876. doi: 10.3748/wjg.v23.i37.6868.
8
Adventures in Developing an App for Covert Hepatic Encephalopathy.
Clin Transl Gastroenterol. 2017 Apr 6;8(4):e85. doi: 10.1038/ctg.2017.14.
9
Covert Hepatic Encephalopathy: Can My Patient Drive?
J Clin Gastroenterol. 2017 Feb;51(2):118-126. doi: 10.1097/MCG.0000000000000764.
10
Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization.
Am J Gastroenterol. 2014 Nov;109(11):1757-63. doi: 10.1038/ajg.2014.264. Epub 2014 Sep 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验